- Home
- UAMY vs OPK Comparison
UAMY vs OPK Comparison
Compare UAMY & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAMY | OPK |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 955.8M | 1.0B |
| IPO Year | 1997 | 2011 |
Fundamental Metrics
Financial Performance| Metric | UAMY | OPK |
|---|---|---|
| Price | $5.22 | $1.44 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $9.44 | $1.60 |
| AVG Volume (30 Days) | ★ 6.3M | 4.4M |
| Earning Date | 05-11-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | N/A |
| Revenue | $39,257,708.00 | ★ $606,879,000.00 |
| Revenue This Year | $219.89 | N/A |
| Revenue Next Year | $104.28 | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 162.80 | N/A |
| 52 Week Low | $4.14 | $0.98 |
| 52 Week High | $19.71 | $1.73 |
Technical Indicators
Market Signals| Indicator | UAMY | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 46.39 | 56.94 |
| Support Level | $4.93 | $1.25 |
| Resistance Level | $6.99 | $1.58 |
| Average True Range (ATR) | 0.42 | 0.06 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 32.51 | 77.75 |
Price Performance
Historical ComparisonAbout UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.